Aspen

12/13 Exchange Place , I.F.S.C., Dublin 1, Ireland
Telephone: + 44 1748 828 391
Medical Information Direct Line: 0800 0087 392
Medical Information e-mail: aspenglobal@professionalinformation.co.uk

Patient Information Leaflet last updated on the eMC: 03/05/2011
PIL Imuran Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/05/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Marketing Authorisation Number
Updated on 04/03/2010 and displayed until 03/05/2011
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 02/06/2009 and displayed until 04/03/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 08/04/2009 and displayed until 02/06/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 24/11/2008 and displayed until 08/04/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 11/06/2007 and displayed until 24/11/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 15/02/2006 and displayed until 11/06/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Change from BAN to rINN
Updated on 24/06/2003 and displayed until 15/02/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 14/03/2003 and displayed until 24/06/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 23/11/2000 and displayed until 14/03/2003
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   azathioprine